Advertisement
Product › Details
SAFIA (suspension array fluorescence immunoassay) technology
Next higher product group | immunoassay technology | |
Status | 2024-02-15 sales existent | |
Organisation | Sysmex Partec GmbH | |
Group | Sysmex (Group) | |
Organisation 2 | SAFIA Technologies GmbH | |
Original research | BAM Bundesanstalt für Materialforschung und -prüfung | |
SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin.
Sysmex Partec GmbH and SAFIA Technologies GmbH agree on a global distribution partnership for SAFIA’s multiplex immunoassay portfolio.
Sysmex Partec GmbH and SAFIA Technologies GmbH are combining their technologies. Together, they offer a solution for the analysis of mycotoxins for food & beverage as well as agriculture industries based on the SAFIA technology and Sysmex Partec Flowcytometry.
The solution is composed of SAFIA’s simple, fast and cost-effective multiplex immunoassay technology and the Sysmex Partec flow cytometer platform. The companies will from now on offer the complete solution to customers through the global Sysmex Partec distribution network with their known standard for high-quality customer support.
Michael Esther, President & CEO of Sysmex Partec GmbH:
"My team and I are looking forward to the start of a fruitful collaboration. Together with business partners around the world, we will contribute to the safety of food and beverages. We will globally provide producers with fast and effective quality control solutions for safe food and beverages that will benefit many people."
Timm Schwaar, Co-Founder of SAFIA Technologies GmbH:
“Mycotoxins pose a widely underestimated threat in food and beverages. As a young and highly innovative company, we take immense pride in collaborating with an experienced partner like Sysmex Partec to address this significant threat to human health together.”
About Sysmex Partec GmbH
Sysmex Partec industrial FCM business unit is developing complete flow cytometry-based solutions for both, rapid screening and rapid specific detection of e.g. water, food & beverage, and agriculture samples. We offer to our customers a state-of-the-art rapid diagnostic for detection, identification and enumeration of microbiological communities and organisms.
Sysmex Partec GmbH, located in Görlitz, Germany, is a subsidiary of the Sysmex Corporation based in Kobe, Japan. We serve our global distribution network of Sysmex regional headquarters, affiliates, distributors and customers.
For more information, visit www.sysmex-partec.com
About SAFIA Technologies GmbH
SAFIA Technologies GmbH specializes in the development, production, and distribution of analysis kits based on the innovative SAFIA (suspension array fluorescence immunoassay) technology. This technology allows for a straightforward mix-and-measure immunoassay, enabling rapid analyses of multiple contaminants in a single measurement.
SAFIA Technologies GmbH is located in Berlin, Germany and was founded by Peter Carl and Timm Schwaar as a spin-off from the Federal Institute for Materials Research and Testing (BAM).
For more information, visit www.safia.tech
Record changed: 2024-02-15 |
Advertisement
More documents for proteomic technology
- [1] Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA....
- [2] DESY. (12/14/23). "Press Release: DESY and CrystalsFirst Team Up to Speed Up the Pre-clinical Drug Discovery Process"....
- [3] Freenome, Inc.. (5/22/23). "Press Release: Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd". South San Francisco, CA....
- [4] CrystalsFirst GmbH. (2/23/23). "Press Release: CrystalsFirst Establishes Partnership with Akttyva Therapeutics to Support AI-powered Drug Discovery Programs". Hamburg....
- [5] Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried....
- [6] Biognosys AG. (5/19/21). "Press Release: Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer". Schlieren....
- [7] Adeptrix Corporation. (1/6/21). "Press Release: Adeptrix Closes Series A Financing to Commercialize BAMS Bioanalytical Reagents for Life Science Research". Beverly, MA....
- [8] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....
- [9] Biognosys AG. (8/27/20). "Press Release: Biognosys Announces Nature Communications Publication in Collaboration with ETH Zurich, Bayer, and BASF". Schlieren....
- [10] Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top